Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Net Margin: 2009-2024

Historic Net Margin for OptimizeRx (OPRX) over the last 16 years, with FY2024 value amounting to 21.83%.

  • OptimizeRx's Net Margin rose 458100.0% to 2.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.41%, marking a year-over-year increase of 404400.0%. This contributed to the annual value of 21.83% for FY2024, which is 27300.0% up from last year.
  • OptimizeRx's Net Margin amounted to 21.83% in FY2024, which was up 27300.0% from 24.56% recorded in FY2023.
  • In the past 5 years, OptimizeRx's Net Margin ranged from a high of 0.62% in FY2021 and a low of 24.56% during FY2023
  • In the last 5 years, OptimizeRx's Net Margin had a median value of 18.32% in 2022 and averaged 13.84%.
  • In the last 5 years, OptimizeRx's Net Margin surged by 76800bps in 2020 and then crashed by -189300bps in 2022.
  • OptimizeRx's Net Margin (Annual) stood at 5.1% in 2020, then surged by 112bps to 0.62% in 2021, then tumbled by -3069bps to 18.32% in 2022, then tumbled by -34bps to 24.56% in 2023, then increased by 11bps to 21.83% in 2024.
  • Its Net Margin was 21.83% in FY2024, compared to 24.56% in FY2023 and 18.32% in FY2022.